Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2009 (2009), Article ID 287974, 6 pages
http://dx.doi.org/10.1155/2009/287974
Research Article

Does Adiponectin Act as an Antiangiogenic Factor in B-Cell Chronic Lymphocytic Leukemia?

1Medical Oncology Unit, Department of Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, 88100 Catanzaro, Italy
2Department of Clinical Pathology, IRCCS Regina Elena, Roma, Italy
3Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy
4Laboratorio di Genetica Molecolare, IRCCS Policlinico, Milano, Italy
5Department of Hematology, Azienda Ospedaliera Verona, Cosenza, Italy
6Department of Human Anatomy and Histology, University of Bari Medical School, Bari, Italy

Received 18 May 2009; Accepted 21 May 2009

Academic Editor: Maher Albitar

Copyright © 2009 Stefano Molica et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Molica, A. Vacca, R. Mirabelli, R. Ria, and D. Ribatti, “Angiogenesis in chronic lymphocytic leukemia: an emerging target,” Clinical Leukemia, vol. 1, pp. 118–122, 2006. View at Google Scholar
  2. S. Molica, G. Vitelli, D. Levato, G. M. Gandolfo, and V. Liso, “Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia,” British Journal of Haematology, vol. 107, no. 3, pp. 605–610, 1999. View at Google Scholar
  3. S. Molica, A. Vacca, D. Ribatti et al., “Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia,” Blood, vol. 100, no. 9, pp. 3344–3351, 2002. View at Publisher · View at Google Scholar
  4. A. Aguayo, H. Kantarjian, T. Manshouri et al., “Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes,” Blood, vol. 96, no. 6, pp. 2240–2245, 2000. View at Google Scholar
  5. A. Ferrajoli, T. Manshouri, Z. Estrov et al., “High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia,” Clinical Cancer Research, vol. 7, no. 4, pp. 795–799, 2001. View at Google Scholar
  6. S. Molica, G. Vitelli, D. Levato et al., “Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression,” European Journal of Haematology, vol. 73, no. 1, pp. 36–42, 2004. View at Publisher · View at Google Scholar
  7. J. L. Frater, N. E. Kay, C. L. Goolsby, S. E. Crawford, G. W. Dewald, and L. C. Peterson, “Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence,” Diagnostic Pathology, vol. 3, no. 1, article 16, 2008. View at Publisher · View at Google Scholar
  8. B. Bauvois, J. Dumont, C. Mathiot, and J.-P. Kolb, “Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons,” Leukemia, vol. 16, no. 5, pp. 791–798, 2002. View at Publisher · View at Google Scholar
  9. T. Funahashi, T. Nakamura, I. Shimomura et al., “Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity,” Internal Medicine, vol. 38, no. 2, pp. 202–206, 1999. View at Google Scholar
  10. T. Kadowaki and T. Yamauchi, “Adiponectin and adiponectin receptors,” Endocrine Reviews, vol. 26, no. 3, pp. 439–451, 2005. View at Publisher · View at Google Scholar
  11. H. Kobayashi, N. Ouchi, S. Kihara et al., “Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin,” Circulation Research, vol. 94, pp. 27–31, 2004. View at Google Scholar
  12. N. Ouchi, H. Kobayashi, S. Kihara et al., “Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells,” The Journal of Biological Chemistry, vol. 279, no. 2, pp. 1304–1309, 2004. View at Publisher · View at Google Scholar
  13. E. Bråkenhielm, N. Veitonmäki, R. Cao et al., “Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 8, pp. 2476–2481, 2004. View at Publisher · View at Google Scholar
  14. S. Molica, G. Vitelli, G. Cutrona et al., “Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia,” International Journal of Hematology, vol. 88, no. 4, pp. 374–380, 2008. View at Google Scholar
  15. C. Pepper, R. Ward, J. Starczynski et al., “Micro-array and protein analyses reveal a preferential autocrine VEGF survival loop in CD38+ sub-clones when compared with CD38- sub-clones derived from the same CLL patient,” Blood, vol. 106, article 56a, 2005. View at Google Scholar
  16. S. Molica, G. Cutrona, G. Vitelli et al., “Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia,” Leukemia Research, vol. 31, no. 11, pp. 1575–1578, 2007. View at Publisher · View at Google Scholar
  17. J. D. Arditi, M. Venihaki, K. P. Karalis, and G. P. Chrousos, “Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer,” Hormone and Metabolic Research, vol. 39, no. 1, pp. 9–13, 2007. View at Publisher · View at Google Scholar
  18. D. Ribatti, B. Nico, E. Crivellato, A. M. Roccaro, and A. Vacca, “The history of the angiogenic switch concept,” Leukemia, vol. 21, no. 1, pp. 44–52, 2007. View at Publisher · View at Google Scholar
  19. N. E. Kay, N. D. Bone, R. C. Tschumper et al., “B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules,” Leukemia, vol. 16, no. 5, pp. 911–919, 2002. View at Publisher · View at Google Scholar
  20. T. D. Shanafelt and N. E. Kay, “The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia,” Seminars in Oncology, vol. 33, no. 2, pp. 174–185, 2006. View at Publisher · View at Google Scholar
  21. P. S. Bora, S. Kaliappan, V. V. Lyzogubov et al., “Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin,” FEBS Letters, vol. 581, no. 10, pp. 1977–1982, 2007. View at Publisher · View at Google Scholar
  22. K. Mahadev, X. Wu, S. Donnelly, R. Ouedraogo, A. D. Eckhart, and B. J. Goldstein, “Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells,” Cardiovascular Research, vol. 78, no. 2, pp. 376–384, 2008. View at Publisher · View at Google Scholar
  23. D. Ribatti, M. T. Conconi, and G. G. Nussdorfer, “Nonclassic endogenous regulators of angiogenesis,” Pharmacological Reviews, vol. 59, no. 2, pp. 185–205, 2007. View at Publisher · View at Google Scholar